peptides for FAQ

Discard it immediately. Cloudiness indicates protein aggregation or contamination. Neither is salvageable. Properly reconstituted peptides should be clear and colorless. Aggregated proteins can trigger immune responses that worsen inflammation rather than resolve it. The error usually occurs during mixing: injecting bacteriostatic water too forcefully into lyophilized powder causes turbulence that denatures peptides. Reconstitute by letting water run slowly down the vial wall, then swirl gently. Never shake.

Unreconstituted lyophilized peptides tolerate short-term ambient temperature (up to 25°C for 24–48 hours), but reconstituted vials must stay at 2–8°C. Use a medical-grade cooler like a FRIO wallet (evaporative cooling, no ice required) or an insulin travel case with reusable ice packs. TSA allows syringes and medication vials in carry-on with a prescription or research documentation letter. Never check peptides in luggage. Cargo hold temperatures fluctuate wildly. If traveling for more than 48 hours without refrigeration access, carry only unreconstituted vials and reconstitute at your destination.

Increase protein intake to 1.8–2.2g per kilogram of body weight and consider whether your deficit has triggered adaptive thermogenesis. If resting energy expenditure has declined, standard interventions (further caloric reduction, increased cardio) often worsen the adaptation rather than overcome it. Research into AMPK-activating compounds investigates whether restoring cellular energy flexibility can break through plateaus caused by metabolic adaptation without requiring further energy restriction. This is mechanistically distinct from increasing caloric deficit—it's about restoring the cellular environment that allows fat oxidation to proceed efficiently.

No. Discard it. Lyophilised peptides tolerate brief temperature excursions (up to 25°C for 24–36 hours maximum), but if a vial arrives noticeably warm or the cold pack has fully melted, protein denaturation has likely occurred. Denatured peptides don't reconstitute properly and won't bind to target receptors effectively. Real Peptides includes temperature monitoring strips in every shipment. If the indicator shows exposure above 8°C for extended periods, contact us for replacement before reconstituting.

Yes. Dramatically. Lyophilised peptides like Dihexa and research-grade Selank must be stored at −20°C before reconstitution. Once mixed with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. A single temperature excursion above 8°C causes irreversible denaturation. The peptide structure unfolds, receptor binding affinity collapses, and the compound becomes biologically inert. This isn't detectable by appearance alone.

Switch to peptides delivered via subcutaneous injection near the affected joint. Oral collagen supplements are hydrolysed proteins broken down into amino acids during digestion—they don't reach cartilage tissue as intact signalling molecules. BPC-157 or TB-500 administered subcutaneously bypass GI degradation and maintain receptor-binding specificity required for FAK-paxillin pathway activation and VEGF upregulation. A 2023 comparative study in Journal of Orthopaedic Research found injectable peptides produced 4.2× greater type II collagen synthesis than oral supplements at equivalent amino acid doses.

Theoretically yes, but interaction data is sparse. Selank modulates monoamine metabolism (dopamine, serotonin, norepinephrine) through enzyme regulation rather than reuptake inhibition, so the mechanistic overlap with SSRIs is minimal. That said, no published trials have evaluated Selank plus SSRI combinations in humans. If you're considering this, work with a prescriber who understands both pharmacologies. Dose adjustments or monitoring intervals may be necessary.

Continue on your regular schedule without doubling up. Peptides for healing work through sustained receptor activation over the repair window. Missing one dose reduces cumulative signaling but doesn't reset the process. Doubling the next dose won't compensate and may oversaturate receptors, which can trigger downregulation (the cell reduces receptor expression in response to excessive ligand binding). Consistency matters more than peak concentration.

Discard the vial. Do not attempt to use it. Lyophilized peptides tolerate ambient temperature before reconstitution, but once mixed with bacteriostatic water, they require refrigeration at 2–8°C. A single temperature excursion above 8°C for more than 2 hours causes protein denaturation, where the peptide's three-dimensional structure unfolds and loses receptor-binding capability. The solution may appear unchanged (clear, no precipitate), but biological activity is compromised or absent. Research institutions using peptides in controlled studies discard any vial with documented temperature deviation. The financial cost of a replacement vial is negligible compared to weeks of ineffective dosing.

Stacking CJC-1295 with ipamorelin is synergistic because they act on different receptors (GHRH vs ghrelin) and produce complementary effects. Baseline amplitude elevation plus pulsatile peaks. Adding a third GH secretagogue like hexarelin typically doesn't provide proportional additional benefit and increases the risk of excessive GH elevation, which can cause joint pain, insulin resistance, and edema. Combining a GH secretagogue with a metabolic peptide like tesofensine targets different pathways (pituitary vs central nervous system) but also compounds side effect profiles.

Absence of effect is the most common outcome when using compounds without established dosing, bioavailability, or ADHD-specific trial data. Peptides like dihexa and P21 lack human pharmacokinetic studies. Optimal dose, administration route, and treatment duration are unknown. If the goal is ADHD symptom management, return to evidence-based options: stimulant therapy, behavioural interventions, or FDA-approved non-stimulants. Research peptides are investigational tools, not therapeutic interventions.

BPC-157 has a half-life of approximately 4 hours. Missing 2–3 days reduces tissue levels to near-baseline. Resume at your regular dose; do not double up. TB-500 has a longer half-life (7–10 days), so missing a single weekly dose doesn't reset the protocol. If you miss more than two consecutive TB-500 doses during maintenance, restart the loading phase. Collagen peptides have no loading period. Missing days simply delays the cumulative benefit timeline. Consistency matters more than perfection.

Lyophilized peptides are stable at room temperature for short periods, but once reconstituted with bacteriostatic water, they must be refrigerated at 2–8°C. Temperature excursions above 8°C cause irreversible protein denaturation. The peptide structure unfolds and loses receptor-binding capability. A vial left out overnight is no longer therapeutically active, even if it looks unchanged. Most peptide degradation is invisible. Potency loss occurs before visible precipitation. Use a dedicated medication cooler if traveling, and discard any reconstituted peptide exposed to ambient temperature for more than two hours.

Reassess dosing frequency, peptide selection, and route of administration. Single-peptide protocols may require combination therapy. Inflammatory bowel disease involves multiple pathways (Th1, Th17, and innate immune activation), and targeting only one mechanism (e.g., NF-κB inhibition with KPV) may not fully suppress disease activity if IL-23/IL-17 signaling remains elevated. Research protocols increasingly combine anti-inflammatory peptides (KPV) with barrier-repair peptides (BPC-157) and immune-modulating peptides (Thymalin) to address inflammation, permeability, and dysregulated adaptive immunity simultaneously. Fecal calprotectin monitoring every two weeks provides objective feedback. Levels above 150 mcg/g indicate persistent mucosal inflammation requiring protocol adjustment.

MK-677 transiently elevates fasting glucose by 5–10 mg/dL in approximately 30% of users due to GH's counter-regulatory effects on insulin. If fasting glucose exceeds 110 mg/dL or HbA1c trends upward, add berberine 500 mg twice daily with meals or reduce MK-677 dose from 25 mg to 12.5 mg. The glucose elevation is not pathological insulin resistance. It's a pharmacological effect of elevated GH blunting insulin's glucose-lowering action. Most research protocols monitoring glucose continuously found the elevation stabilized within 4–6 weeks and reversed entirely upon cessation. If glucose remains elevated beyond 6 weeks or exceeds 120 mg/dL fasting, discontinue MK-677 and consult a prescribing physician.

Absence of response within 14 days doesn't indicate failure if the peptide's mechanism requires sustained BDNF elevation or synaptic remodeling. Structural neuroplasticity takes 4–8 weeks. Cerebrolysin trials documented continued HDRS score improvement through week 4 even when early-phase changes were modest. Assess storage conditions first. Temperature excursions above 8°C denature peptides irreversibly. If storage was correct and dosing verified, consider switching compounds or returning to evidence-based pharmacotherapy rather than extending an unproven protocol indefinitely.

Peptides cannot regenerate cartilage that has eroded to bone-on-bone contact. Once the cartilage layer is functionally absent, the substrate for chondrocyte activity no longer exists. No peptide can rebuild tissue from zero. Peptides show the most promise in early-to-moderate degeneration where cartilage thinning has occurred but some structural integrity remains. In advanced OA, peptides may reduce inflammation and support surrounding soft tissue (tendons, ligaments), but they will not reverse the joint space narrowing visible on X-ray.

Start HCG at 500 IU three times weekly and expect gradual recovery over 12–18 months, not weeks. Testicular volume may increase 10–15% within the first three months, but full recovery to baseline is uncommon once atrophy exceeds 30%. A 2021 study from the University of Utah found that men who added HCG after 12+ months of testosterone monotherapy regained an average of 8% testicular volume after 24 months of HCG use. Significant but not complete reversal. If fertility is the goal, add recombinant FSH (75–150 IU three times weekly) alongside HCG to accelerate spermatogenic recovery.

Reduce the dose by 50% and split into twice-daily administration. Dihexa's HGF receptor binding can trigger rapid synaptic remodeling that outpaces glial support cell adaptation. Manifesting as headaches, sensory sensitivity, or sleep disruption. A slower titration (starting at 0.25mg/kg and increasing weekly) allows astrocyte and oligodendrocyte populations to scale alongside neuronal changes. If symptoms persist below threshold dose, Dihexa may not be appropriate for that patient's current neural substrate.

The honest assessment: peptides may slow synaptic loss without preventing disease onset entirely, meaning you could still develop Alzheimer's but potentially 5–10 years later than without intervention. This is not failure. Delaying onset from age 70 to age 80 meaningfully compresses the period of dependency and preserves quality of life. The financial calculation depends on what delay is worth to you. Cerebrolysin cycles cost $800–$1,500 per month during active treatment phases. Dihexa and P21 research-grade peptides cost significantly less but lack any human efficacy benchmarks.